IN8bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.About INAB
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S.
CEOWilliam T. Ho
CEOWilliam T. Ho
Employees18
Employees18
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2016
Founded2016
Employees18
Employees18
INAB Key Statistics
Market cap14.48M
Market cap14.48M
Price-Earnings ratio-0.32
Price-Earnings ratio-0.32
Dividend yield—
Dividend yield—
Average volume687.45K
Average volume687.45K
High today$0.1679
High today$0.1679
Low today$0.1562
Low today$0.1562
Open price$0.1678
Open price$0.1678
Volume497.90K
Volume497.90K
52 Week high$1.74
52 Week high$1.74
52 Week low$0.133
52 Week low$0.133
People also own
Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.